Innovation Pharmaceuticals Inc (IPIX)

[Drano]

Characterizing something as a "fortuitous bit of clinical happenstance" is disingenuous.

The CEO of the company has far more data than he can publicly disclose. The fact that he chose to disclose that, after probably being inundated by shareholder queries, indicates his confidence that the data will prove to be meaningful.

This company has possible treatments or perhaps even cures in 4 ongoing human trials, for:
cancer
resistant infections
oral mucositis
psoriasis

Anyone who thinks that a stock should be trading at this low market cap when it has this number of clinical trials, QIDP designation from the FDA, trials being run by one of the most prestigious research centers in the world, and an entirely NEW family of antibiotics (the first since 1987) -- well, I can't even find words to express my disbelief that anyone could actually believe that, much less write it with a straight face.